These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 26395311

  • 1. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
    Ruskoné-Fourmestraux A, Matysiak-Budnik T, Fabiani B, Cervera P, Brixi H, Le Malicot K, Nion-Larmurier I, Fléjou JF, Hennequin C, Quéro L, Groupe d’Étude des Lymphomes Digestifs (GELD) & Fédération Francophone de Cancérologie Digestive.
    Radiother Oncol; 2015 Oct; 117(1):178-82. PubMed ID: 26395311
    [Abstract] [Full Text] [Related]

  • 2. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Sugimoto M, Kajimura M, Shirai N, Furuta T, Kanaoka S, Ikuma M, Sato Y, Hishida A.
    Intern Med; 2006 Oct; 45(6):405-9. PubMed ID: 16617193
    [Abstract] [Full Text] [Related]

  • 3. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S, Sugiyama T, Matsumoto T, Iijima K, Ono S, Tajika M, Tari A, Kitadai Y, Matsumoto H, Nagaya T, Kamoshida T, Watanabe N, Chiba T, Origasa H, Asaka M, JAPAN GAST Study Group.
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [Abstract] [Full Text] [Related]

  • 4. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W, Goebeler-Kolve ME, Dragosics B, Greiner A, Stolte M.
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [Abstract] [Full Text] [Related]

  • 5. Sequential H. pylori eradication and radiation therapy with reduced dose compared to standard dose for gastric MALT lymphoma stages IE & II1E: a prospective randomized trial.
    Schmelz R, Miehlke S, Thiede C, Brueckner S, Dawel M, Kuhn M, Ruskoné-Formestraux A, Stolte M, Jentsch C, Hampe J, Morgner A.
    J Gastroenterol; 2019 May; 54(5):388-395. PubMed ID: 30327875
    [Abstract] [Full Text] [Related]

  • 6. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S, Matsumoto T, Suekane H, Nakamura S, Matsumoto H, Esaki M, Yao T, Iida M.
    Cancer; 2005 Aug 01; 104(3):532-40. PubMed ID: 15937928
    [Abstract] [Full Text] [Related]

  • 7. Regression of gastric high grade mucosa associated lymphoid tissue (MALT) lymphoma after Helicobacter pylori eradication.
    Montalban C, Santon A, Boixeda D, Bellas C.
    Gut; 2001 Oct 01; 49(4):584-7. PubMed ID: 11559658
    [Abstract] [Full Text] [Related]

  • 8. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
    Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C.
    Haematologica; 2001 Jun 01; 86(6):609-17. PubMed ID: 11418369
    [Abstract] [Full Text] [Related]

  • 9. Development of early gastric cancer 4 and 5 years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type.
    Morgner A, Miehlke S, Stolte M, Neubauer A, Alpen B, Thiede C, Klann H, Hierlmeier FX, Ell C, Ehninger G, Bayerdörffer E.
    World J Gastroenterol; 2001 Apr 01; 7(2):248-53. PubMed ID: 11819769
    [Abstract] [Full Text] [Related]

  • 10. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series.
    Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Wündisch T, Neubauer A, Raderer M, Savio A, EGILS (European Gastro-Intestinal Lymphoma Study) Group.
    Gut; 2007 Dec 01; 56(12):1685-7. PubMed ID: 17639089
    [Abstract] [Full Text] [Related]

  • 11. Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
    Begum S, Sano T, Endo H, Kawamata H, Urakami Y.
    J Med Invest; 2000 Feb 01; 47(1-2):36-46. PubMed ID: 10740978
    [Abstract] [Full Text] [Related]

  • 12. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856
    [Abstract] [Full Text] [Related]

  • 13. A Prospective Trial of Radiation Therapy Efficacy and Toxicity for Localized Mucosa-associated Lymphoid Tissue (MALT) Lymphoma.
    Fang P, Gunther JR, Pinnix CC, Dong W, Strati P, Nastoupil LJ, Steiner RE, Ahmed S, Damron EP, Fowler N, Nair R, Westin JR, Neelapu S, Ha CS, Dabaja BS.
    Int J Radiat Oncol Biol Phys; 2021 Apr 01; 109(5):1414-1420. PubMed ID: 33309978
    [Abstract] [Full Text] [Related]

  • 14. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW, Gospodarowicz MK, Pintilie M, Bezjak A, Wells W, Hodgson DC, Crump M.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1258-64. PubMed ID: 11483337
    [Abstract] [Full Text] [Related]

  • 15. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma.
    Streubel B, Ye H, Du MQ, Isaacson PG, Chott A, Raderer M.
    Oncology; 2004 Aug 01; 66(6):476-80. PubMed ID: 15452377
    [Abstract] [Full Text] [Related]

  • 16. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy.
    Fischbach W, Dorlöchter C.
    Z Gastroenterol; 2019 May 01; 57(5):593-599. PubMed ID: 31083747
    [Abstract] [Full Text] [Related]

  • 17. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status.
    Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S.
    Am J Gastroenterol; 2008 Jan 01; 103(1):62-70. PubMed ID: 17894851
    [Abstract] [Full Text] [Related]

  • 18. Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: an Italian, multicentre study.
    Andriani A, Miedico A, Tedeschi L, Patti C, Di Raimondo F, Leone M, Schinocca L, Romanelli A, Bonanno G, Linea C, Giustini M, Hassan C, Cottone M, Zullo A.
    Dig Liver Dis; 2009 Jul 01; 41(7):467-73. PubMed ID: 18945654
    [Abstract] [Full Text] [Related]

  • 19. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Abe S, Oda I, Inaba K, Suzuki H, Yoshinaga S, Nonaka S, Morota M, Murakami N, Itami J, Kobayashi Y, Maeshima AM, Saito Y.
    Jpn J Clin Oncol; 2013 Sep 01; 43(9):917-22. PubMed ID: 23878345
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response].
    Montalbán C, Manzanal A, Boixeda D, Redondo C, Alvarez I, Frutos B, Calleja JL, Sánchez-Godoy P, Bellas C.
    Med Clin (Barc); 1998 Jan 24; 110(2):41-4. PubMed ID: 9534129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.